Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Financial year 2021/22: Sonova delivers solid results
and significantly advances its growth strategy
Financial year 2021/22: Sonova delivers solid results and significantly advances its growth strategy
Financial year 2021/22: Sonova delivers solid results and significantly advances its growth strategy
Update on the timeline for Vifor Pharma tender offer: https://mms.businesswire.com/media/20191103005014/en/691947/5/VP_logo_rgb.jpg
Update on the timeline for Vifor Pharma tender offer


Regulatory News:



CSL Limited (ASX: CSL; USOTC:CSLLY) yesterday announced an update regarding the Vifor Pharma AG acquisition. CSL has previously advised that it expected to be in a position to

Update zum Zeitplan des öffentlichen Kaufangebots für Vifor Pharma: https://mms.businesswire.com/media/20191103005014/en/691947/5/VP_logo_rgb.jpg
Update zum Zeitplan des öffentlichen Kaufangebots für Vifor Pharma


Regulatory News:



CSL Limited (ASX: CSL; USOTC:CSLLY) hat gestern ein Update bezüglich der Übernahme der Vifor Pharma AG veröffentlicht. CSL hat zuvor mitgeteilt, dass das Unternehmen die

SFS completes transaction with Hoffmann
SFS completes transaction with Hoffmann
SFS completes transaction with Hoffmann
Jonas Van Holanda is the winner of the 2022 Helvetia Art Prize
Jonas Van Holanda is the winner of the 2022 Helvetia Art Prize
Jonas Van Holanda is the winner of the 2022 Helvetia Art Prize
Dufry wins two new six-year duty-free and duty-paid contracts at Salvador International Airport in Brazil
Dufry wins two new six-year duty-free and duty-paid contracts at Salvador International Airport in Brazil
Dufry wins two new six-year duty-free and duty-paid contracts at Salvador International Airport in Brazil
Baloise supports young curators at Art Forum Baloise Park
Baloise supports young curators at Art Forum Baloise Park
Baloise supports young curators at Art Forum Baloise Park
PSP Swiss Property with a successful Q1 2022.
Improved ebitda guidance.
PSP Swiss Property with a successful Q1 2022. Improved ebitda guidance.
PSP Swiss Property with a successful Q1 2022. Improved ebitda guidance.
Baloise Group reports a robust SST ratio of 220 per cent
Baloise Group reports a robust SST ratio of 220 per cent
Baloise Group reports a robust SST ratio of 220 per cent
Annual General Meeting of Bâloise Holding Ltd: shareholders vote in favour of the proposals by the Board of Directors
Annual General Meeting of Bâloise Holding Ltd: shareholders vote in favour of the proposals by the Board of Directors
Annual General Meeting of Bâloise Holding Ltd: shareholders vote in favour of the proposals by the Board of Directors
Shareholders' Meeting elects Thomas Schmuckli as Chairman of the Board of Directors
Shareholders' Meeting elects Thomas Schmuckli as Chairman of the Board of Directors
Shareholders' Meeting elects Thomas Schmuckli as Chairman of the Board of Directors
Helvetia with an excellent SST ratio of 260%
Helvetia with an excellent SST ratio of 260%
Helvetia with an excellent SST ratio of 260%
Kapruvia® approved by European Commission for the treatment of moderate-to-severe pruritus in hemodialysis patients: https://mms.businesswire.com/media/20191103005014/en/691947/5/VP_logo_rgb.jpg
Kapruvia® approved by European Commission for the treatment of moderate-to-severe pruritus in hemodialysis patients


Regulatory News:


This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220427005801/en/



Vifor Fresenius Medical Care Renal Pharma (VFMCRP)

Straumann Group reports very strong first quarter
Straumann Group reports very strong first quarter
Straumann Group reports very strong first quarter
SFS shareholders approve all proposals at the Annual General Meeting
SFS shareholders approve all proposals at the Annual General Meeting
SFS shareholders approve all proposals at the Annual General Meeting
Continued sales growth despite mounting challenges
Continued sales growth despite mounting challenges
Continued sales growth despite mounting challenges
94th Vifor Pharma Group Annual General Meeting: https://mms.businesswire.com/media/20191103005014/en/691947/5/VP_logo_rgb.jpg
94th Vifor Pharma Group Annual General Meeting


Regulatory News:



At today’s 94th Annual General Meeting of Vifor Pharma Ltd., shareholders approved all proposed resolutions put forward by the Board of Directors. The Annual General Meeting was

94. Generalversammlung der Vifor Pharma Gruppe: https://mms.businesswire.com/media/20191103005014/en/691947/5/VP_logo_rgb.jpg
94. Generalversammlung der Vifor Pharma Gruppe


Regulatory News:



An der heutigen 94. ordentlichen Generalversammlung der Vifor Pharma AG haben die Aktionäre alle Anträge des Verwaltungsrats genehmigt. Die Generalversammlung fand erneut

DGAP-Adhoc: BB Biotech AG publishes its interim report
DGAP-Adhoc: BB Biotech AG publishes its interim report
DGAP-Adhoc: BB Biotech AG publishes its interim report
DGAP-News: BB BIOTECH AG: Increased investment level balanced by established core holdings
DGAP-News: BB BIOTECH AG: Increased investment level balanced by established core holdings
DGAP-News: BB BIOTECH AG: Increased investment level balanced by established core holdings
Cembra shareholders approve all proposals of the Board of Directors
Cembra shareholders approve all proposals of the Board of Directors
Cembra shareholders approve all proposals of the Board of Directors
Dufry wins new duty-free and duty-paid contract at Sofia International Airport in Bulgaria
Dufry wins new duty-free and duty-paid contract at Sofia International Airport in Bulgaria
Dufry wins new duty-free and duty-paid contract at Sofia International Airport in Bulgaria
To the Financial Community: https://mms.businesswire.com/media/20220331005538/en/1406690/5/oe_pos_rgb.jpg
To the Financial Community
To the Financial Community
Shareholders approved all resolutions via the Independent Proxy: https://mms.businesswire.com/media/20220331005538/en/1406690/5/oe_pos_rgb.jpg
Shareholders approved all resolutions via the Independent Proxy
Shareholders approved all resolutions via the Independent Proxy
Aktionäre genehmigten sämtliche Anträge über die unabhängige Stimmrechtsvertreterin: https://mms.businesswire.com/media/20220331005538/en/1406690/5/oe_pos_rgb.jpg
Aktionäre genehmigten sämtliche Anträge über die unabhängige Stimmrechtsvertreterin
Aktionäre genehmigten sämtliche Anträge über die unabhängige Stimmrechtsvertreterin